
Statins can exert dual, concentration dependent effects on HCV entry in vitro
Keywords: HCV; Statins; CLDN-1; LDLR; NPC1L1; CD81; PCSK9; Lipids; CholesterolHMG-CoAR, 3-hydroxy-3-methylglutharyl-coenzyme A reductase; PEG-IFN, pegylated interferon; SVR, sustained viral response; LDLR, low density lipoprotein receptor; NPC1L1, Niemann–Pick C1-l